Aralez Pharmaceuticals Q3 2016 Earnings Call Results

Aralez Pharmaceuticals' Q3 2016 earnings presentation covering corporate overview and financial results presented on November 7, 2016. The presentation discusses key product launches including YOSPRALA and ZONTIVITY, the acquisition of Toprol-XL U.S. rights, and updated 2016 financial guidance on revenues and operating expenses.